Advancing joint care with evidence-based therapies.
Omni Pharma is a specialty distribution partner dedicated to orthopedic and rheumatologic pain management. We work with global manufacturers to bring validated therapies to healthcare professionals — and are expanding into regenerative medicine.
Clinically validated
Only therapies backed by peer-reviewed evidence, regulatory clearances, and manufacturer quality systems.
Regulatory & quality first
Full compliance across registration, storage, and cold-chain distribution — auditable end-to-end.
Long-term partnerships
We build enduring relationships with clinicians and manufacturers who share our standards.
Therapeutic areas we serve
Purposefully narrow, so we can go deep. Every therapy we distribute is selected for the patients seen by our partner specialists.
Supintro — advanced viscosupplementation
Developed by our partner ERC Bio, Supintro is a sodium hyaluronate intra-articular therapy designed to restore synovial fluid viscoelasticity and reduce pain in patients with osteoarthritis.
- High molecular weight sodium hyaluronate
- Single- and multi-injection protocols
- Manufactured under EU quality standards
Trusted by manufacturers who set the standard
We collaborate with leading international manufacturers to bring their therapies to specialists in our region — with the quality, regulatory, and commercial support they expect.
Bring a proven therapy to specialists in our region.
We work with manufacturers whose products meet our quality bar and serve the patients our specialists treat every day.